Stockscreener 앱 받기
4.01
8.03%
-0.35
시장 영업 전:
3.92
-0.09
-2.24%
전일 마감가:
$4.36
열려 있는:
$4.35
하루 거래량:
3.70M
Relative Volume:
0.60
시가총액:
$1.09B
수익:
$8.10M
순이익/손실:
$-92.72M
주가수익비율:
-11.23
EPS:
-0.3571
순현금흐름:
$-82.52M
1주 성능:
+2.30%
1개월 성능:
-20.59%
6개월 성능:
+71.37%
1년 성능:
+81.45%
1일 변동 폭
$3.98
$4.35
1주일 범위
$3.6929
$4.495
52주 변동 폭
$1.05
$5.5082
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
명칭
Taysha Gene Therapies Inc
전화
(214) 612-0000
주소
3000 PEGASUS PARK DRIVE, DALLAS
TSHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
4.01 | 1.19B | 8.10M | -92.72M | -82.52M | -0.3571 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2025-07-11 | 개시 | BofA Securities | Buy |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-04-09 | 개시 | Piper Sandler | Overweight |
| 2023-02-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-03-09 | 개시 | Robert W. Baird | Outperform |
| 2022-03-01 | 개시 | Wells Fargo | Overweight |
| 2022-02-18 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | Guggenheim | Buy |
| 2021-07-16 | 개시 | Needham | Buy |
| 2021-06-24 | 개시 | Truist | Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-06-09 | 개시 | Wedbush | Outperform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 재개 | Jefferies | Buy |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-01-05 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-19 | 개시 | Goldman | Buy |
| 2020-10-19 | 개시 | Jefferies | Buy |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
How Taysha Gene Therapies Inc. stock benefits from strong dollarJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
Is Taysha Gene Therapies Inc. stock near bottom after declineWeekly Risk Report & Consistent Profit Alerts - newser.com
Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Will Taysha Gene Therapies Inc. stock recover after recent drop2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo
Short interest data insights for Taysha Gene Therapies Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Custom watchlist performance reports with Taysha Gene Therapies Inc.July 2025 Price Swings & High Return Trade Guides - newser.com
Can Taysha Gene Therapies Inc. hit a new high this monthJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Commit To Purchase Taysha Gene Therapies At $2.50, Earn 24% Using Options - Nasdaq
Detecting support and resistance levels for Taysha Gene Therapies Inc.2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Candlestick signals on Taysha Gene Therapies Inc. stock todayBuy Signal & Accurate Entry and Exit Point Alerts - newser.com
Will breakout in Taysha Gene Therapies Inc. lead to full recoveryPortfolio Performance Report & Technical Pattern Based Signals - newser.com
How institutional ownership impacts Taysha Gene Therapies Inc. stockWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-09 05:46:32 - newser.com
Citizens Lifts Price Target for Taysha Gene Therapies (TSHA) - Insider Monkey
Taysha Gene Therapies Hits Day Low at $3.97 Amid Price Pressure - Markets Mojo
Taysha Gene Therapies Inc. (TSHA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can momentum traders help lift Taysha Gene Therapies Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Why Taysha Gene Therapies Inc. stock is rated strong buyPortfolio Value Report & Safe Entry Momentum Tips - newser.com
Taysha Gene Therapies Inc (TSHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Taysha Gene Therapies Inc 주식 (TSHA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar | President and Head of R&D |
Sep 10 '25 |
Option Exercise |
0.70 |
41,150 |
28,760 |
1,206,439 |
| Nagendran Sukumar | President and Head of R&D |
Sep 10 '25 |
Sale |
3.23 |
200,000 |
646,000 |
1,006,439 |
0.35%
0.75%
자본화:
|
볼륨(24시간):